194 related articles for article (PubMed ID: 26759329)
1. Long-term functional results of aspiration and sclerotherapy with ethanol in patients with autosomal dominant polycystic kidney disease: a non-randomized pilot clinical study.
Küçük EV; Tahra A; Bindayi A; Suçeken FY; Önol FF; Boylu U
Int Urol Nephrol; 2016 Apr; 48(4):457-63. PubMed ID: 26759329
[TBL] [Abstract][Full Text] [Related]
2. Selective ablation of symptomatic dominant renal cysts using 99% ethanol in adult polycystic kidney disease.
Singh I; Mehrotra G
Urology; 2006 Sep; 68(3):482-7; discussion 487-8. PubMed ID: 17010722
[TBL] [Abstract][Full Text] [Related]
3. Ablation of symptomatic cysts using absolute ethanol in 11 patients with autosomal-dominant polycystic kidney disease.
Lee YR; Lee KB
Korean J Radiol; 2003; 4(4):239-42. PubMed ID: 14726641
[TBL] [Abstract][Full Text] [Related]
4. Single-session percutaneous sclerotherapy in symptomatic simple renal cysts: long-term results.
Aribas BK; Dingil G; Doğan K; Kaya G; Unlü DN; Yilmaz K; Sahin G; Simsek Z; Demir P
Minerva Urol Nefrol; 2009 Jun; 61(2):129-36. PubMed ID: 19451895
[TBL] [Abstract][Full Text] [Related]
5. Renal cyst ablation with n-butyl cyanoacrylate and iodized oil in symptomatic patients with autosomal dominant polycystic kidney disease: preliminary report.
Kim SH; Moon MW; Lee HJ; Sim JS; Kim SH; Ahn C
Radiology; 2003 Feb; 226(2):573-6. PubMed ID: 12563157
[TBL] [Abstract][Full Text] [Related]
6. Treatment of renal cysts with single-session percutaneous drainage and ethanol sclerotherapy: long-term outcome.
Paananen I; Hellström P; Leinonen S; Merikanto J; Perälä J; Päivänsalo M; Lukkarinen O
Urology; 2001 Jan; 57(1):30-3. PubMed ID: 11164138
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous aspiration and ethanolamine oleate sclerotherapy for sustained resolution of symptomatic polycystic liver disease: an initial experience.
Nakaoka R; Das K; Kudo M; Chung H; Innoue T
AJR Am J Roentgenol; 2009 Dec; 193(6):1540-5. PubMed ID: 19933645
[TBL] [Abstract][Full Text] [Related]
8. Long-term results of single-session percutaneous drainage and ethanol sclerotherapy in simple renal cysts.
Akinci D; Akhan O; Ozmen M; Gumus B; Ozkan O; Karcaaltincaba M; Cil B; Haliloglu M
Eur J Radiol; 2005 May; 54(2):298-302. PubMed ID: 15837413
[TBL] [Abstract][Full Text] [Related]
9. Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease.
Uemasu J; Fujihara M; Munemura C; Nakamura E; Kawasaki H
Nephrol Dial Transplant; 1996 May; 11(5):843-6. PubMed ID: 8671906
[TBL] [Abstract][Full Text] [Related]
10. Center is an important indicator for choice of invasive therapy in polycystic liver disease.
D'Agnolo HM; Kievit W; van Munster KN; van der Laan JJ; Nevens F; Drenth JP
Transpl Int; 2017 Jan; 30(1):76-82. PubMed ID: 27732751
[TBL] [Abstract][Full Text] [Related]
11. The comparison of percutaneous ethanol and polidocanol sclerotherapy in the management of simple renal cysts.
Yonguc T; Sen V; Aydogdu O; Bozkurt IH; Yarimoglu S; Polat S
Int Urol Nephrol; 2015 Apr; 47(4):603-7. PubMed ID: 25778818
[TBL] [Abstract][Full Text] [Related]
12. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function.
Lee DI; Andreoni CR; Rehman J; Landman J; Ragab M; Yan Y; Chen C; Shindel A; Middleton W; Shalhav A; McDougall EM; Clayman RV
J Endourol; 2003 Aug; 17(6):345-54. PubMed ID: 12965058
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-guided aspiration and ethanol sclerotherapy (EST) for treatment of cyst recurrence in patients after previous endometriosis surgery: analysis of influencing factors using a decision tree.
Chang MY; Hsieh CL; Shiau CS; Hsieh TT; Chiang RD; Chan CH
J Minim Invasive Gynecol; 2013; 20(5):595-603. PubMed ID: 24034537
[TBL] [Abstract][Full Text] [Related]
14. Carbohydrate antigen 19-9 is significantly elevated in autosomal dominant polycystic kidney disease.
Fukasawa H; Kaneko M; Niwa H; Yasuda H; Kumagai H; Furuya R
Nephrology (Carlton); 2018 Mar; 23(3):210-216. PubMed ID: 28024168
[TBL] [Abstract][Full Text] [Related]
15. Rationale and design of the TEMPO (Tolvaptan Efficacy and Safety in Management of Autosomal Dominant Polycystic Kidney Disease and its Outcomes) 3-4 Study.
Torres VE; Meijer E; Bae KT; Chapman AB; Devuyst O; Gansevoort RT; Grantham JJ; Higashihara E; Perrone RD; Krasa HB; Ouyang JJ; Czerwiec FS
Am J Kidney Dis; 2011 May; 57(5):692-9. PubMed ID: 21333426
[TBL] [Abstract][Full Text] [Related]
16. A randomized study of aspiration and sclerotherapy versus laparoscopic deroofing in management of symptomatic simple renal cysts.
Agarwal M; Agrawal MS; Mittal R; Sachan V
J Endourol; 2012 May; 26(5):561-5. PubMed ID: 22091534
[TBL] [Abstract][Full Text] [Related]
17. Treatment of symptomatic simple renal cysts by percutaneous aspiration and ethanol sclerotherapy.
Mohsen T; Gomha MA
BJU Int; 2005 Dec; 96(9):1369-72. PubMed ID: 16287460
[TBL] [Abstract][Full Text] [Related]
18. Effects of topical instillation of minocycline hydrochloride on cyst size and renal function in polycystic kidney disease.
Uemasu J; Fujiwara M; Munemura C; Tokumoto A; Kawasaki H
Clin Nephrol; 1993 Mar; 39(3):140-4. PubMed ID: 8462201
[TBL] [Abstract][Full Text] [Related]
19. Long-term follow-up of large symptomatic hepatic cysts treated by percutaneous ethanol sclerotherapy.
Jang SY; Park SY; Tak WY; Kweon YO; Ryeom H
Acta Radiol; 2016 Oct; 57(10):1205-9. PubMed ID: 26787678
[TBL] [Abstract][Full Text] [Related]
20. Symptom relief and not cyst reduction determines treatment success in aspiration sclerotherapy of hepatic cysts.
Neijenhuis MK; Wijnands TFM; Kievit W; Ronot M; Gevers TJG; Drenth JPH
Eur Radiol; 2019 Jun; 29(6):3062-3068. PubMed ID: 30542749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
